Biphasic mechanism of the toxicity induced by 1-methyl-4-phenylpyridinium ion (MPP+) as revealed by dynamic changes in glucose metabolism in rat brain slices-Reference-Cited by-同舟云学术

Biphasic mechanism of the toxicity induced by 1-methyl-4-phenylpyridinium ion (MPP+) as revealed by dynamic changes in glucose metabolism in rat brain slices

Published:2007-05 Issue:3 Volume:28 Page:672-678
ISSN:0161-813X
Container-title:NeuroToxicology
language:en
Short-container-title:NeuroToxicology

Author:

Maruoka Nobuyuki,Murata Tetsuhito,Omata Naoto,Takashima Yasuhiro,Fujibayashi Yasuhisa,Wada Yuji

Publisher

Elsevier BV

Subject

Toxicology,General Neuroscience

Reference51 articles.

1. Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Could oxidative stress be involved in the brain?;Adams;Biochem Pharmacol,1991

2. Involvement of free radicals in MPP+ neurotoxicity against rat dopaminergic neurons in culture;Akaneya;Neurosci Lett,1995

3. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?;Beal;Ann Neurol,1992

4. Brain iron pathways and their relevance to Parkinson's disease;Berg;J Neurochem,2001

5. Chronic systemic pesticide exposure reproduces features of Parkinson's disease;Betarbet;Nat Neurosci,2000

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Environmental Contribution to Redox Dyshomeostasis in Parkinson’s Disease;Molecular and Integrative Toxicology;2022

2. Attenuation of Endoplasmic Reticulum Stress, Impaired Calcium Homeostasis, and Altered Bioenergetic Functions in MPP+-Exposed SH-SY5Y Cells Pretreated with Rutin;Neurotoxicity Research;2019-05-04

3. Metabolic Dysfunction in Parkinson’s Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism;Brain Research Bulletin;2017-07

4. Mitochondrial control of cell bioenergetics in Parkinson’s disease;Free Radical Biology and Medicine;2016-11

5. Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson’s disease;Pharmacological Research;2016-01